ResearcherSoochow UniversityActive in the last 2 years

Khemayanto Hidayat

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4095-6969; OpenAlex author ID A5052502915. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 2

Tumor Microenvironment-Responsive Nanoreactor Induces Disulfidptosis in Pancreatic Cancer via Metabolic Interference and Redox Catalysis. Co-author DOI 10.1002/advs.76146 ↗
A systematic review and meta-analysis of observational studies of the association between the use of incretin-based therapies and the risk of pancreatic cancer. Co-author DOI 10.1002/pds.5550 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Su Hu · 1 shared paper, 2026 · strength 0.28
- Paper Tumor Microenvironment-Responsive Nanoreactor Induces Disulfidptosis in Pancreatic Cancer via Metabolic Interference an… DOI 10.1002/advs.76146 ↗
Rui Fu · 1 shared paper, 2026 · strength 0.28
- Paper Tumor Microenvironment-Responsive Nanoreactor Induces Disulfidptosis in Pancreatic Cancer via Metabolic Interference an… DOI 10.1002/advs.76146 ↗
Qi Li · 1 shared paper, 2026 · strength 0.28
- Paper Tumor Microenvironment-Responsive Nanoreactor Induces Disulfidptosis in Pancreatic Cancer via Metabolic Interference an… DOI 10.1002/advs.76146 ↗
Zeng‐Ning Li · 1 shared paper, 2023 · strength 0.22
- Paper A systematic review and meta-analysis of observational studies of the association between the use of incretin-based the… DOI 10.1002/pds.5550 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.